METAL-ORGANIC FRAMEWORKS AS ION-TO-ELECTRON TRANSDUCERS AND DETECTORS

    公开(公告)号:WO2019033104A1

    公开(公告)日:2019-02-14

    申请号:PCT/US2018/046510

    申请日:2018-08-13

    CPC分类号: G01N27/3335 G01N27/308

    摘要: Embodiments of the present disclosure pertain to ion-selective electrodes that include a metal-organic framework and an electrode surface. The metal-organic framework is associated with the electrode surface in a manner that forms an interface between the metal-organic framework and the electrode surface. Additional embodiments pertain to methods of detecting an ion in a sample by associating the sample with the ion- selective electrodes of the present disclosure. The metal-organic frameworks of the ion-selective electrodes mediate ion-to- electron transduction through the interface between the metal-organic frameworks and the electrode surface. Thereafter, the presence or absence of the ion in the sample is detected by detecting a change in potential of the ion-selective electrode and correlating the change in the potential to the presence or absence of the ion. The metal organic frameworks may simultaneously mediate ion sensing and ion-to-electron transduction through the interface between the metal-organic frameworks and the electrode surface.

    MOLECULARLY-IMPRINTED-POLYMER COATED CONDUCTIVE NANOPARTICLES FOR COTININE DETECTION, AND ASSOCIATED DEVICES AND METHODS
    25.
    发明申请
    MOLECULARLY-IMPRINTED-POLYMER COATED CONDUCTIVE NANOPARTICLES FOR COTININE DETECTION, AND ASSOCIATED DEVICES AND METHODS 审中-公开
    用于CO检测的分子印迹聚合物涂覆的导电纳米颗粒及相关装置和方法

    公开(公告)号:WO2017176830A1

    公开(公告)日:2017-10-12

    申请号:PCT/US2017/026056

    申请日:2017-04-05

    摘要: A device for detecting cotinine includes (a) a film that includes a plurality of molecularly-imprinted-polymer (MIP) coated conductive nanoparticles having specific affinity for binding with cotinine, and (b) two electrodes in contact with the film for passing electrical current through the film to detect binding with cotinine as a change in electrical conductivity of the film. A MIP coated conductive nanoparticle for detecting cotinine includes (a) a conductive nanoparticle, (b) a silicon dioxide coating formed on the conductive nanoparticle and forming a first shell around the conductive nanoparticle, and (c) an MIP coating formed on the silicon dioxide coating and forming the second shell, wherein the MIP coating includes a polymer molecularly imprinted with cotinine to provide specific affinity for binding of cotinine to the MIP coated conductive nanoparticle such that the cotinine is detectable as a change in electrical conductivity of the MIP coated conductive nanoparticle.

    摘要翻译: 用于检测可替宁的装置包括(a)包含多个具有与可替宁结合的特异性亲和力的分子印迹聚合物(MIP)涂布的导电纳米颗粒的薄膜,和(b) 与膜接触以使电流通过膜以检测与可替宁的结合,作为膜的电导率的变化。 (a)导电纳米颗粒,(b)形成在导电纳米颗粒上并在导电纳米颗粒周围形成第一壳的二氧化硅涂层,和(c)在二氧化硅上形成的MIP涂层 涂覆并形成第二壳,其中所述MIP涂层包括分子印迹有可替宁的聚合物,以提供对可替宁结合到MIP涂覆的导电纳米粒子的特异性亲和力,使得可替宁可作为MIP涂覆的导电纳米粒子的电导率变化

    E2F4 SIGNATURE FOR USE IN DIAGNOSING AND TREATING BREAST AND BLADDER CANCER
    29.
    发明申请
    E2F4 SIGNATURE FOR USE IN DIAGNOSING AND TREATING BREAST AND BLADDER CANCER 审中-公开
    E2F4用于诊断和治疗乳腺癌和乳腺癌的标志

    公开(公告)号:WO2016018524A1

    公开(公告)日:2016-02-04

    申请号:PCT/US2015/036567

    申请日:2015-06-19

    发明人: CHENG, Chao

    IPC分类号: C12N5/09

    摘要: Methods for treating breast and bladder cancer patients based upon E2F4 regulatory activity as a predictor of relapse of a patient with estrogen receptor positive breast cancer and in bladder cancer stratification are provided. This invention is a method of administering an aggressive breast cancer treatment (a) providing a ER+ breast tumor tissue sample from a patient; (b) measuring the expression of genes regulated by transcription factor E2F4 in the ER+ breast tumor tissue sample; (c) inferring changes in transcription factor E2F4 activity in the ER+ breast tumor tissue sample using the measured expression in (b); (d) comparing the inferred changes in transcription factor. E2F4 activity in the ER+ breast tumor tissue sample to transcription factor E2F4 activity in a reference sample; and (e) administering an aggressive breast cancer treatment to the patient when the ER+ breast tumor tissue sample has higher transcription factor E2F4 activity than in the reference sample.

    摘要翻译: 提供了基于E2F4调节活性作为雌激素受体阳性乳腺癌和膀胱癌分层患者复发的预测因子的乳腺癌和膀胱癌患者的治疗方法。 本发明是一种施用侵袭性乳腺癌治疗(a)从患者提供ER +乳腺肿瘤组织样品的方法; (b)测量ER +乳腺肿瘤组织样本中转录因子E2F4调控基因的表达; (c)使用(b)中的测量表达推断ER +乳腺肿瘤组织样品中转录因子E2F4活性的变化; (d)比较推断的转录因子变化。 E2F4活性在ER +乳腺肿瘤组织样本中转录因子E2F4活性参考样品中; 和(e)当ER +乳腺肿瘤组织样品具有比参照样品更高的转录因子E2F4活性时,对患者进行侵袭性乳腺癌治疗。

    METHODS FOR MODULATING THE INTERACTION BETWEEN DIGUANYLATE CYCLASE AND A COGNATE EFFECTOR PROTEIN OR PHOSPHODIESTERASE
    30.
    发明申请
    METHODS FOR MODULATING THE INTERACTION BETWEEN DIGUANYLATE CYCLASE AND A COGNATE EFFECTOR PROTEIN OR PHOSPHODIESTERASE 审中-公开
    用于调节二元醇环化酶与COGNATE EFFECTOR蛋白或磷酸二酯酶之间相互作用的方法

    公开(公告)号:WO2015175868A1

    公开(公告)日:2015-11-19

    申请号:PCT/US2015/030954

    申请日:2015-05-15

    IPC分类号: A61K31/10

    摘要: Methods for inhibiting the physical interaction between a guanylate cyclase a cognate effector protein or phosphodiesterase, and modulating biofilm formation are provided. The present invention provides a method for inhibiting the physical interaction between a guanylate cyclase a cognate effector protein or phosphodiesterase, and a method for modulating biofilm formation by contacting a bacterial cell expressing a guanylate cyclase and a cognate effector protein or phosphodiesterase with an effective amount of a agent that modulates the physical and specific interaction between the guanylate cyclase and cognate effector protein or phosphodiesterase. In some embodiments, the agent is a peptide or peptidomimetic.

    摘要翻译: 提供了抑制鸟苷酸环化酶与同源效应蛋白或磷酸二酯酶之间的物理相互作用以及调节生物膜形成的方法。 本发明提供了抑制鸟苷酸环化酶与同源效应蛋白或磷酸二酯酶之间的物理相互作用的方法,以及通过使表达鸟苷酸环化酶的细菌细胞和同源效应子蛋白或磷酸二酯酶与有效量的 调节鸟苷酸环化酶和同源效应蛋白或磷酸二酯酶之间的物理和特异性相互作用的试剂。 在一些实施方案中,所述试剂是肽或肽模拟物。